This study is in progress, not accepting new patients
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
a study on Cognition Disorders
Summary
- Eligibility
- for people ages 65-85 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Eli Lilly and Company
- Links
- more information about this study: A Study of Solanezumab in Older Participants Who May be at Risk for Memory Loss (A4)
- ID
- NCT02008357
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated